Holen Sie sich die Stockscreener-App
53.15
1.01%
0.53
Handel nachbörslich:
53.13
-0.02
-0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$52.62
Offen:
$52.94
24-Stunden-Volumen:
9.77M
Relative Volume:
0.75
Marktkapitalisierung:
$62.83B
Einnahmen:
$368.91B
Nettoeinkommen (Verlust:
$5.02B
KGV:
13.49
EPS:
3.94
Netto-Cashflow:
$1.69B
1W Leistung:
+3.06%
1M Leistung:
+19.82%
6M Leistung:
-10.78%
1J Leistung:
-27.41%
1-Tages-Spanne:
$52.21
$53.27
1-Wochen-Bereich:
$50.63
$53.27
52-Wochen-Spanne:
$43.56
$80.75
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
53.15 | 62.83B | 368.91B | 5.02B | 1.69B | 3.94 |
|
UNH
Unitedhealth Group Inc
|
524.99 | 484.79B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
389.22 | 90.27B | 174.02B | 6.42B | 871.00M | 27.43 |
|
CI
Cigna Group
|
288.59 | 80.27B | 229.75B | 3.04B | 5.18B | 10.60 |
|
HUM
Humana Inc
|
284.67 | 34.28B | 115.01B | 1.36B | -4.34B | 11.29 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
Why Is CVS Health Corporation (CVS) Among the Best High-Yield Dividend Stocks to Invest In? - Insider Monkey
Culbertson A N & Co. Inc. Sells 9,599 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Purchased by Park Avenue Securities LLC - Defense World
Polianta Ltd Grows Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Trust Co. of Vermont - MarketBeat
CVS Health Co. (NYSE:CVS) Stake Lowered by Albert D Mason Inc. - MarketBeat
CVS Health: One Ugly Chart, Leverage Issues, Trump Problems, Recession/Competition Risks (NYSE:CVS) - Seeking Alpha
Avanza Fonder AB Makes New $4.75 Million Investment in CVS Health Co. (NYSE:CVS) - MarketBeat
Empirical Asset Management LLC Purchases 32,860 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS (CVS Health) Forward Dividend Yield % : 5.06% (As of Jan. 19, 2025) - GuruFocus.com
CVS Health Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Is CVS Health (CVS) the Best Fortune 500 Dividend Stock to Buy Right Now? - Insider Monkey
CVS Health (NYSE:CVS) Stock Price Up 1.1%Time to Buy? - MarketBeat
Dividend Roundup: Citigroup, Procter & Gamble, Caterpillar, CVS Health, and more - Seeking Alpha
CVS Health Co. (NYSE:CVS) Stock Holdings Decreased by Gateway Investment Advisers LLC - MarketBeat
Assenagon Asset Management S.A. Lowers Stock Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health (NYSE:CVS) Stock Price Down 0.6%Time to Sell? - MarketBeat
CVS Health Isn't Going To The Dogs - Seeking Alpha
CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Insurance, Pharmacy Benefit Manager Company Stocks Drop Following UnitedHealth's Q4 Revenue Miss: What's Going On? - Benzinga
CVS Health (NYSE:CVS) Stock Price Down 1.7%Here's Why - MarketBeat
FTC to bring lawsuit against CVS, Cigna, and UnitedHealth Group - The American Bazaar
Several Setbacks Dragged CVS Health Corp. (CVS) in Q4 - MSN
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know - MSN
Oak Thistle LLC Invests $837,000 in CVS Health Co. (NYSE:CVS) - MarketBeat
Claro Advisors LLC Decreases Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Corp. stock rises Wednesday, still underperforms market - MarketWatch
Is CVS Health (CVS) the Hottest Large-Cap Stock So Far in 2025? - Insider Monkey
Healthcare: Sector Looks Undervalued with Pullback After US Election and Obesity Data - Morningstar
CVS Health (NYSE:CVS) Trading Up 1.1%Still a Buy? - MarketBeat
Why UnitedHealth and CVS Are Set to Dominate the $21 Billion Medicare Advantage Surge - Yahoo Canada Finance
CVS Health Corp (CVS)'s Uncertain Future: Understanding the Barriers to Outperformance - GuruFocus.com
CVS stock retains Overweight rating on expected developments - Investing.com
Meyer Handelman Co. Sells 9,103 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Radnor Capital Management LLC Trims Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
3 Dividend Stocks at Bargain Levels to Defend Your Portfolio - MarketBeat
CVS Health: Current Price Offers Favorable Risk-Reward Profile - Yahoo Finance
Can Integrated Healthcare Stocks Succeed in Public Markets? - Benzinga
CVS CEO Exit Ends Promising Era of Women Heading Pharmacy Chains - MSN
FTC accuses CVS, Cigna, UnitedHealth of abusing middleman role, shares down - MSN
CVS Accused of Illegal Opioid Dispensing in Federal Suit - MSN
What You Need To Know Ahead of CVS Health's Earnings Release - Nasdaq
CVS Health Corp. stock rises Tuesday, still underperforms market - MarketWatch
Do Dr. Oz's Health Care Stocks Create a Conflict of Interest? - MSN
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role - Bloomberg
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role (3) - Bloomberg Law
FTC says CVS, Cigna, and UnitedHealth abuse middleman role - The Boston Globe
US FTC finds major pharmacy benefit managers inflated drug prices for $7.3 billion gain - Yahoo News Canada
FTC Accuses CVS, Cigna, UnitedHealth of Abusing Middleman Role - Bloomberg Law
Why CVS Health (CVS) Led the Monday Upsurge? - MSN
What You Need To Know Ahead Of CVS Health's Earnings Release - Barchart
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):